Podcast and Video: In today’s podcast and accompanying video, Dr. Blevins discusses and illustrates the case of a patient with a double pituitary adenoma.
From J D Faccinetti, chief editor co-founder – First, some background: the latest edition of the WHO (World Health Organization) Endocrine Tumors and Central Nervous System Tumors group reclassified pituitary adenomas as neuroendocrine tumors or
From Lewis S Blevins, Jr. M.D. – Long-term follow-up of patients with pituitary disorders is essential for many reasons. Firstly, those patients who have been rendered disease-free are always at risk for recurrence. While long-term
In today’s podcasts, Dr. Blevins talks about the genesis of pseudo Cushing’s syndrome and illustrates a fascinating case of pseudo Cushing’s syndrome due to alcohol ingestion.
This book, edited by world-renowned clinicians and editors Dr. Manish Aghi and Dr. Lewis Blevins, delivers a guide to medical decision-making on diagnosing and treating acromegaly.
COR2ED is an independent medical education company based in Europe. They have partnered with a scientific committee comprising endocrinologists, nurses, and patient advocacy groups (WAPO and INCA) to develop two surveys to explore the injection
A commentary from Lewis S. Blevins Jr. M.D. – Dr. Lewis Blevins reviews a recent article published by Mohyeldin and others from Stanford University in Scientific Reports.
From Dr. Ezequiel (Eze) Goldschmidt and UCSF Health Medconnection a collection of minimally invasive skull base surgery cases. UCSF’s Ezequiel (Eze) Goldschmidt, MD, PhD, is a neurosurgeon specializing in minimally invasive techniques, including the endoscopic endonasal
From the University of California, San Francisco, (UCSF) MedConnection comes a fascinating article about a patient with a giant pituitary adenoma removed via endoscopic endonasal surgery.
In this podcast oriented to physicians, Dr. Lewis Blevins talks about a case of a patient with a pituitary lesion called a hemangiopericytoma invasive in the right cavernous sinus. Although the content is technical, patients and other interested parties may find the discussion interesting.
In today’s podcast directed to physicians, PWN co-founder Dr. Lewis Blevins discusses the drug Recolev® (levoketoconazole) recently approved by the FDA to treat endogenous Cushing’s Syndrome.